In certain cases, venom molecules are developed to counter unexpected adverse effects found with human components such as the venom DNP-based cenderitide developed to overcome the deleterious hypotensive effects of nesiritide, the recombinant human BNP used as a drug for the treatment of HF. The gene discussed is NPPB; the disease is hydrops fetalis.